CTRI/2023/09/057176
Not yet recruiting
Phase 2
A randomized open-label pilot study to assess the pharmacoeconomic & therapeutic outcome in schizophrenia patients with aripiprazole regimen based on genetic polymorphism - NI
AJIITH XAVIER F0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: F209- Schizophrenia, unspecified
- Sponsor
- AJIITH XAVIER F
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Schizophrenia patients who will be started on aripiprazole therapy
- •2\.Patients \>16 years of either gender
- •3\.Patient or legally authorized representative willing to give informed consent
Exclusion Criteria
- •1\.Patients with chronic liver or kidney disease
- •2\.Pregnant and lactating females
- •3\. History of neurological, neuroendocrine, or other medical conditions known to affect the central nervous system.
- •4\. Any significant medical condition that has clinically significant interaction with aripiprazole
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
An open label, randomized pilot study to evaluate diagnostic treatment interruption in HIV-positive children under a stable antiretroviral therapy in order to save medication and reduce possible side effects.B24Unspecified human immunodeficiency virus [HIV] diseaseDRKS00000473J.W. Goethe UniversitätZentrum für Kinder- und Jugendmedizin1
Not yet recruiting
Phase 2
Evaluation the efficacy of Siddha medicine (Soothaga Mezhugu) for the treatment of Polycystic Ovarian Syndrome.CTRI/2024/06/068998il
Active, not recruiting
Phase 1
A randomized, open label pilot study to investigate the effect of chronic administration of buprenorphine prior to arthroplasty on the opioid requirements of patients intraoperatively and postoperatively. - Date: Final 26 April 2004EUCTR2005-003009-10-GBBarts and The London NHS Trust75
Recruiting
Phase 2
Study to evaluate the efficacy of Sucralfate as a healing agent in bed sores.CTRI/2016/03/006745Internal FLUID Grant Christian Medical College Vellore30
Completed
Not Applicable
An open label, cross over pilot study to evaluate the effect of a single dose of TW001 on the oxidative stress and pharmacokinetics with and without food in patients with amyotrophic lateral sclerosisNL-OMON42324Treeway B.V.8